|
Product |
Size |
Catalog # |
|
C-Myc Peptide |
1 mg |
24194 |
|
EQKLISEEDL |
|
C-Myc Peptide |
5 mg |
20590 |
|
EQKLISEEDL |
|
Caerulein |
0.5 mg |
24251 |
|
PyrQDY(SO3H)-TGWMDF-NH2 |
|
Caerulein |
1 mg |
24252 |
|
PyrQDY(SO3H)-TGWMDF-NH2 |
|
β-Casomorphin, human |
5 mg |
24249 |
|
YPFVEPI |
|
β-Casomorphin, human |
25 mg |
24250 |
|
YPFVEPI |
|
Cathepsin L Substrate |
1 mg |
24192 |
|
FITC-LC-EKARVLAEAAK(DABCYL) |
|
Cathepsin L Substrate |
5 mg |
24193 |
|
FITC-LC-EKARVLAEAAK(DABCYL) |
|
GR23118 |
0.5 mg |
24418 |
|
(IEPDap-YRLRY-NH2)2 (Linkage: E2(1)-Dpr4(2) and
Dpr4(1)-E2(2)) |
|
GR23118 |
1 mg |
24419 |
|
(IEPDap-YRLRY-NH2)2 (Linkage: E2(1)-Dpr4(2) and
Dpr4(1)-E2(2)) |
|
Guanylin, human |
0.5 mg |
24265 |
|
PGTCEICAYAACTGC (Disulfide bridge: 4-12 and 7-15) |
|
Guanylin, human |
1 mg |
24266 |
|
PGTCEICAYAACTGC (Disulfide bridge: 4-12 and 7-15) |
|
HA Peptide |
1 mg |
21156 |
|
YPYDVPDYA |
|
HA Peptide |
5 mg |
21158 |
|
YPYDVPDYA |
|
HEL (46-61) |
1 mg |
60504-1 |
|
NTDGSTDYGILQINSR |
|
Hexa-His |
1 mg |
24420 |
|
HHHHHH |
|
Hexa-His |
5 mg |
24421 |
|
HHHHHH |
|
Hexa-Tyr |
1 mg |
20264 |
|
YYYYYY |
|
Hexa-Tyr |
5 mg |
20265 |
|
YYYYYY |
|
Laminin Pentapeptide |
1 mg |
20805 |
|
YIGSR |
|
Laminin Pentapeptide |
5 mg |
20806 |
|
YIGSR |
|
Laminin Pentapeptide, amide |
1 mg |
24023 |
|
YIGSR-NH2 |
|
Laminin Pentapeptide, amide |
5 mg |
24024 |
|
YIGSR-NH2 |
|
Interleukin-6 Receptor |
1 mg |
24426 |
|
TSLPVQDSSSVP |
|
Interleukin-6 Receptor |
5 mg |
24427 |
|
TSLPVQDSSSVP |
|
KL-1 |
1 mg |
24430 |
|
LPPVAASSLRND |
|
KL-1 |
5 mg |
27015 |
|
LPPVAASSLRND |
|
L-Selectin |
1 mg |
27020 |
|
CQKLDKSFSMIK |
|
L-Selectin |
5 mg |
27021 |
|
CQKLDKSFSMIK |
|
Leupeptin |
1 mg |
21695 |
|
Ac-LLR-CHO |
|
Leupeptin |
5 mg |
27267 |
|
Ac-LLR-CHO |
|
Mastoparan |
1 mg |
24270 |
|
INLKALAALAKKIL-NH2 |
|
Mastoparan |
5 mg |
24269 |
|
INLKALAALAKKIL-NH2 |
|
MKKp2 |
1 mg |
27022 |
|
SKGKSKRKKDLRISCNSK |
|
MKKp2 |
5 mg |
27023 |
|
SKGKSKRKKDLRISCNSK |
|
MycC Peptide |
1 mg |
25070 |
|
YEQLRNSRA |
|
MycC Peptide |
5 mg |
25071 |
|
YEQLRNSRA |
|
DOTA-Octreotide |
1 mg |
29889 |
|
DOTA-fCFwKTCT-ol (Disulfide bridge: 2-7) |
|
DOTA-Octreotide |
5 mg |
29890 |
|
DOTA-fCFwKTCT-ol (Disulfide bridge: 2-7) |
|
DOTA-Octreotide Acid |
1 mg |
29899 |
|
DOTA-fCFwKTCT (Disulfide bridge: 2-7) |
|
DOTA-Octreotide Acid |
5 mg |
29900 |
|
DOTA-fCFwKTCT (Disulfide bridge: 2-7) |
|
DOTA-[Tyr3]-Octreotide |
1 mg |
24195 |
|
DOTA-fCYwKTCT-ol (Disulfide bridge: 2-7) |
|
DOTA-[Tyr3]-Octreotide |
5 mg |
24196 |
|
DOTA-fCYwKTCT-ol (Disulfide bridge: 2-7) |
|
DOTA-[Tyr3]-Octreotide Acid |
1 mg |
60018-1 |
|
DOTA-fCYwKTCT (Disulfide bridge: 2-7) |
|
DOTA-[Tyr3]-Octreotide Acid |
5 mg |
60018-5 |
|
DOTA-fCYwKTCT (Disulfide bridge: 2-7) |
|
Peptide Standard 1 |
0.5 mg |
22495 |
|
CPDFGHIAMELSVRTWKY |
|
Peptide Standard 1 |
1 mg |
22496 |
|
CPDFGHIAMELSVRTWKY |
|
Pro-TGF-α |
1 mg |
27034 |
|
HADLLAVVAASQ |
|
Pro-TGF-α |
5 mg |
27035 |
|
HADLLAVVAASQ |
|
RPI (Prenyl Protein Inhibitor) |
1 mg |
23731 |
|
Boc-C(Farnesyl)CH2NVIM |
|
RPI (Prenyl Protein Inhibitor) |
5 mg |
23732 |
|
Boc-C(Farnesyl)CH2NVIM |
|
Sauvagine |
0.5 mg |
24475 |
|
PyrGPPISIDLSLELLRKMIEIEKQEKEKQQAANNRLLLDTI-NH2 |
|
Sauvagine |
1 mg |
25238 |
|
PyrGPPISIDLSLELLRKMIEIEKQEKEKQQAANNRLLLDTI-NH2 |
|
TIP 39 (39 mer) |
1 mg |
21687 |
|
SLALADDAAFRERARLLAALERRHWLNSYMHKLLVLDAP |
|
TIP 39 (39 mer) |
5 mg |
27046 |
|
SLALADDAAFRERARLLAALERRHWLNSYMHKLLVLDAP |
|
Tyr-W-M1F1 |
1 mg |
27049 |
|
YPWG-NH2 |
|
Tyr-W-M1F1 |
5 mg |
27050 |
|
YPWG-NH2 |
|
Urotensin II, human (hydrochloride form) |
1 mg |
27051 |
|
ETPDCFWKYCVlHCL (Disulfide bridge: 5-10) |
|
Urotensin II, human (hydrochloride form) |
5 mg |
27052 |
|
ETPDCFWKYCVlHCL (Disulfide bridge: 5-10) |
|
Urotensin II, rat; [pGlu110]-Prepro-Urotensin II (110-123), rat |
1 mg |
27053 |
|
PyrHGTAPECFWKYCI (Disulfide bridge: 8-13) |
|
Urotensin II, rat; [pGlu110]-Prepro-Urotensin II (110-123), rat |
5 mg |
27054 |
|
PyrHGTAPECFWKYCI (Disulfide bridge: 8-13) |
|
Vanilloid Receptor Subtype 1 (VR1) |
1 mg |
27055 |
|
CEDAEVFKDSMVPGEK |
|
Vanilloid Receptor Subtype 1 (VR1) |
5 mg |
27056 |
|
CEDAEVFKDSMVPGEK |
|
VSV-G Peptide |
1 mg |
21152 |
|
YTDIEMNRLGK |
|
VSV-G Peptide |
5 mg |
21154 |
|
YTDIEMNRLGK |
|
aKChaVAAWTLKAAaAhxC |
1 mg |
24173 |
|
aKChaVAAWTLKAAaAhxC |
|
aKChaVAAWTLKAAaAhxC |
5 mg |
24174 |
|
aKChaVAAWTLKAAaAhxC |
|
IELLQAR (8-βranch MAPS) |
1 mg |
24424 |
|
IELLQAR |
|
IELLQAR (8-βranch MAPS) |
5 mg |
24425 |
|
IELLQAR |
|
klaklakklaklak-NH2 |
1 mg |
23576 |
|
klaklakklaklak-NH2 |
|
klaklakklaklak-NH2 |
5 mg |
23577 |
|
klaklakklaklak-NH2 |
|
PTNVGSNTY-NH2 |
1 mg |
27032 |
|
PTNVGSNTY-NH2 |
|
PTNVGSNTY-NH2 |
5 mg |
27033 |
|
PTNVGSNTY-NH2 |
|
SKIGKV-NH2 |
5 mg |
27047 |
|
SKIGKV-NH2 |
|
SKIGKV-NH2 |
25 mg |
27048 |
|
SKIGKV-NH2 |
|
Sulforhodamine 101-YSRALpSRQLSS (also known as Texas Red™-YSRALpSRQLSS) |
1 mg |
27044 |
|
Sulforhodamine 101-YSRALpSRQLSS |
|
Sulforhodamine 101-YSRALpSRQLSS (also known as Texas Red™-YSRALpSRQLSS) |
5 mg |
27045 |
|
Sulforhodamine 101-YSRALpSRQLSS |
|
WKYMVm-NH2 |
1 mg |
27069 |
|
WKYMVm-NH2 |
|
WKYMVm-NH2 |
5 mg |
27070 |
|
WKYMVm-NH2 |
